Updated:
Foundation Medical Partners
Foundation Medical Partners invests in early-stage medical device and health-tech companies from offices in six US innovation hubs.
Foundation Medical Partners
Foundation Medical Partners invests in early-stage companies developing medical devices, diagnostics, and digital health technologies. The firm maintains a presence in Minneapolis, Boston, Cambridge, New York, Portola Valley, and Marlborough, placing it within major US hubs for medical innovation. The firm's investment approach centers on transformational healthcare technologies that address unmet clinical needs. The firm targets seed through Series B rounds, focusing on regulated medical technologies with clear regulatory pathways. Its portfolio spans interventional cardiology, orthopedics, neurology, and digital health platforms. Foundation Medical Partners works closely with academic medical centers and research institutions to identify technologies emerging from translational research. The firm participates in both syndicated rounds and direct investments, often collaborating with other specialized healthcare investors. Foundation Medical Partners maintains a geographically distributed team aligned with its office locations, enabling proximity to portfolio companies and academic collaborators. The firm's operational model emphasizes active board participation and strategic guidance through regulatory approval and commercialization. Recent public records indicate the firm continues to invest from its latest fund vehicle, though specific fund size and vintage remain undisclosed. Foundation Medical Partners' multi-office structure across six life-science clusters represents a deliberate sourcing architecture. Rather than centralizing in a single venture hub, the firm embeds investment professionals in proximity to the academic medical centers and device incubators that generate its pipeline — a distributed model more common in seed-stage medtech than in generalist venture firms.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Additional offices
New York, NY · Boston, MA · Cambridge, MA · Portola Valley, CA · Marlborough, MA
Sector focus
Frequently asked questions
What investment stages does Foundation Medical Partners target?
The firm focuses on seed through Series B rounds in medical device, diagnostic, and digital health companies. Its investment window typically spans from initial proof-of-concept through clinical validation and early commercialization. The firm seeks opportunities where regulatory strategy and clinical evidence generation are central to value creation.
How does Foundation Medical Partners source its deal flow?
Foundation Medical Partners sources opportunities through relationships with academic medical centers, research institutions, and medical device incubators. Its six-office footprint across Minneapolis, Boston, Cambridge, New York, Portola Valley, and Marlborough places investment professionals within major medtech clusters, enabling proximity-based sourcing. The firm also collaborates with syndicate partners who co-invest across the specialized healthcare venture ecosystem.
Is Foundation Medical Partners structured as a single family office or a venture capital firm?
Foundation Medical Partners operates as a single family office deploying proprietary capital into early-stage healthcare ventures. The firm functions with the investment discipline of a specialized venture investor but without external limited partners. This structure enables patient capital and concentrated portfolio construction uncommon in traditional fund vehicles.
Which sectors does Foundation Medical Partners explicitly avoid?
Foundation Medical Partners does not invest in therapeutics, biotech drug development, or traditional pharmaceutical assets. The firm's mandate is concentrated on regulated medical devices, diagnostics, and digital health platforms. Service-oriented healthcare businesses and healthcare IT companies without a regulated device or diagnostic component are also typically outside scope.
What is Foundation Medical Partners' known posture on co-investments alongside external venture firms?
The firm regularly co-invests alongside specialized healthcare venture funds and occasionally with generalist firms that lack dedicated medtech expertise. Foundation Medical Partners' proprietary capital base allows it to serve as a flexible syndicate partner, often contributing domain expertise in regulatory strategy and clinical trial design alongside its capital commitment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: